Featured Articles
NMPA New Approvals in January 2023
In January 2023, NMPA approved 124 medical devices, including 11 Class III imported products, 12 Class II imported products, and 99 Class III domestic products.
Below is a list of approved Class III and Class II imported products in January 2023.
Medical Device/IVD | Manufacturer | Category |
Cardiac Resynchronization Device Tiered-therapy Cardioverter/Defibrillator | St. Jude Medical Coordination Center BVBA | Class III |
Bio-Medicus Life Support Catheter and Introducer | Medtronic, Inc. | Class III |
BD Vacutainer® Safety-Lok™ Blood Collection Set | Becton Dickinson and Company | Class III |
Belotero Volume Lidocaine | Anteis SA | Class III |
Athletis OVER-THE-WIRE PTA Balloon Dilatation Catheter | Boston Scientific Corporation | Class III |
Restylane Volyme | Q-Med AB | Class III |
TiBases and Screws | Zfx GmbH | Class III |
Medical X-Ray angiography equipment | GE MEDICAL SYSTEMS SCS | Class III |
Diagnostic Ultrasound System | ESAOTE S.p.A. | Class III |
Ultrasound Diagnostic Equipment | SUPERSONIC IMAGINE | Class III |
Cardiac Resynchronization Device Tiered-therapy Cardioverter/Defibrillator | St.Jude Medical Coordination Center BVBA | Class III |
Dissecting Tools | Medtronic Powered Surgical Solutions | Class II |
Riptide™ Large Bore Aspiration Tubing | Micro Therapeutics, Inc.DBA ev3 Neurovascular | Class II |
Vertebroplasty Adjuncts | Seawon Meditech Co., Ltd. | Class II |
Subcyclo Probe | QUANTEL MEDICAL | Class II |
HDL Cholesterol Calibrator (HDLC CAL) | Class II | |
QUANTA-Lyser 3000 ELISA/IFA + Incubator | INOVA Diagnostics, Inc. | Class II |
Automatic air mattress systems | Care of Sweden AB | Class II |
Mobile ECG Atrial Fibrillation Alert Software | 삼성전자(주) | Class II |
Wrist0x2 Pulse 0ximeter | Nonin Medical,Inc. | Class II |
Diagnostic X-Ray tube | VAREX IMAGING CORPORATION | Class II |
Skater Fix | Argon Medical Devices, Inc. | Class II |
Aqua Maris® Strong nasal spray | Jadran-Galenski laboratorij d.d. | Class II |
NMPA CMDE Annual Report for Year 2022
The Center For Medical Device Evaluation of NMPA (NMPA CMDE for short) has made a summary of the work in 2022, the report is as follows:
Ⅰ. Registration application
It accepted 20,865 applications for registration of medical devices, including 5,389 filing changes, 2,035 imported Class I filing. A total of 13,066 applications were transferred to the technical review process, the transfer of the finalized project 14,486, 1,300 more than in 2021, an increase of 9.9 percent year-on-year.
II. Emergency Review Status
- 11 Nucleic acid test kit
- 10 Antibody test kit
- 47 Antigen detection kits
- 2 Medical device products
III. Review time
Application Type | Product Category | Average review time | Average time for expert consultation | Average time for applicant supplementary phase | Total time |
Product Registration | Class II | 72 | 0 | 245 | 317 |
Class III | 99 | 1 | 178 | 278 | |
Class II+Class III | 95 | 1 | 187 | 283 | |
Registration change of permitted matters | Class II | 45 | 0 | 81 | 126 |
Class III | 69 | 0 | 60 | 129 | |
Class II+Class III | 64 | 0 | 64 | 128 | |
Renewal Registration | Class II | 24 | 0 | 13 | 37 |
Class III | 46 | 0 | 28 | 74 | |
Class II+Class III | 39 | 0 | 24 | 62 |
IV. Collective decision-making
- 29 meetings of CMDE technical meetings
- 679 meetings of CMDE branch technical meetings
Ⅴ. Deficiency letter, expert panel meeting and audit
- Supplementary Information for deficiency letter
Issued 5,698 deficiency letters
Received 5,626 items of supplementary dossiers - Expert panel meeting
Initiated 114 expert panel meetings
Organized 107 expert panel meetings - QMS audit
Initiated 2,465 QMS audits
Received 2,125 auditing results
Ⅵ. Innovation and priority review
Special review of innovative medical devices
- Received 343 innovation applications, up 37.8% year-on-year;
- Organized and held 309 expert review meetings;
- Completed review of 361 items.
Priority approval for medical device audits
- Received 31 priority approval requests, down 24.4% year-on-year;
- Organized 13 expert review meetings;
- Completed the review of 34 items.
Ⅶ. Manufacturer consulting
Provided 7,717 times ofpre-acceptance consultation
Provided 6,466 times of supplementary dossier consultation
The Ministry Of Finance of China Reduces Tariffs On Imported Medical Devices
To protect human health and reduce patients’ economic burden, the Ministry of Finance of the People’s Republic of China issued the tariff adjustment plan on December 29, and will reduce import tariffs for 13 types of medical devices from January 1, 2023; and 37 types of medical device products will achieve zero import tariffs.
Policy Highlights
Further reduction of import tariffs for some medical devices
China will implement provisional import tax rates lower than the most-favored-nation (MFN) tariff rate for 1020 items. Among them, 13 types of medical devices such as spring rings, dentures, raw materials for vascular stents and contrast agents will achieve further reduction in import tariffs starting Jan 1, 2023.
Zero import tariff for some medical devices
The eighth step of tariff reduction will be implemented for the MFN tariff rate of the products listed in the Amendment to the Tariff Concession Schedule of the World Trade Organization Accession Protocol of the People’s Republic of China for the expansion of the information technology agreement. After the implementation of the policy, 37 types of medical device products will achieve zero tariff on imports starting July 1, 2023.
New tax item for surgical robots
In the adjustment of import and export tariffs, it is clear that surgical robot tax items will be increased in 2023 to meet the needs of industrial development and scientific and technological progress. Surgical robot refers to a medical device consisting of a robotic arm, console, imaging system and other components that can perform complex surgical operations in a minimally invasive manner. Including orthopedic surgery robot, neurosurgery robot, radiation interventional surgery robots.
NMPA Facilitates the Usage of Medical Device Master Files
The NMPA issued a notice on further clarifying matters related to the registration and use of the master files of medical devices on January 18, 2023.
Combined with the registration and use of medical device master files, the following matters are clarified:
- Medical device master file is a form of technical data, such data is submitted directly by its owner to the medical device regulator, used to authorize the applicant for registration of medical device products in the declaration of medical device registration and other matters. The registration of medical device master file is a voluntary act.
- Medical device master file registration is mainly related to medical device raw materials. Medical device master file system applies to the medical device registration applicant in China’s imports of Class II, Class III and domestic Class III medical devices (including in vitro diagnostic reagents) registration, changes, clinical trial approval and other applications referenced in the registration of the master file. According to the actual situation, local NMPA can carry out the main file registration items of domestic Class II medical devices by referring to this announcement.
New China CER Website
The new website was built based on the newly updated clinical evaluation requirements and regulation in China under the Order 739.
We are here to help you obtain China market approval for your medical devices with a comprehensive Clinical Evaluation Report (CER). Before jumping to any conclusions, use our newly developed tool for a
Resources – Webinar/Short Videos
Please click here to review the record of BradyKnows webinar and short videos.
- Revisiting 2022 And Looking Into 2023: Regulatory Updates For Medical Device Market Access In China
- Keep Up With The Trend Of Medical Devices Localization In China: Background, Policy, Regulation, And Case Study
- What is Hainan Boao Lecheng International Medical Tourism Pilot Zone?
- What Can International Medical Device Manufacturer Do in Hainan Medical Tourism Pilot Zone?
- Hainan Urgent Use Program for International Medical Device Manufacturers
- China’s Medical Device -Clinical Evaluation Pathways
- Real-World Evidence for NMPA Premarket Clinical Evaluation
- Faster China NMPA Approval via Real-World Study in Hainan
- Commercial & Regulatory Benefits of Entering Hainan Pilot Zone
- Usage of Real-World Evidence for Medical Devices China vs. US
- If One Of A Product’s Performance Indicator Values Is Formulated Based On Relevant Industry Standards,but There Is No Relevant Requirement For Such Performance Indicator In The Standard After The Industry Standard Updates, How Should The Performance Indicator Be Determined?
- Does It Need To Add Warning Information Related To DEHP To The Instructions For Use Of Infusion Set Products Made Of DEHP-plasticized Polyvinyl Chloride (PVC)?
- What Should Be Included In The Label Of The Whole Blood And Blood Component Storage Bag (hereinafter Referred To As The “blood Bag”)?
- Is It Necessary To Supplement The Risk Reminder For The Use Of Lubricants In The Instructions For Use Of Urinary Catheter Products?
- Non-active Ophthalmic Products, Such As Contact Lenses And Intraocular Lenses, Generally Take The Improvement Of Vision As The Efficacy Indicator In Clinical Trials. At Present The Standard Logarithmic Visual Acuity Chart Is Actually More Used In Clinical Practice In China. Is This Visual Acuity Chart Recognized?
- How To Determine The Orthodontic Bracket Belong To Products Listed In The “Catalogue Of Medical Devices Exempted From Clinical Trials”?
- How To Select The Clinical Evaluation Method For Magnetic Attachment?
- Are Adhesive-backed Polyurethane Foam Dressings Covered By The “Polyurethane Foam Dressings” In The Catalogue Of Class III Medical Devices Exempted From Clinical Trials?
- The Product Under Application Includes Both Cervical Intervertebral Fusion Cage And Lumbar Intervertebral Fusion Cage. If Clinical Trials Are Carried Can Just One Of These Fusion Cages Be Selected For The Clinical Trial Or Must Both Cervical And Thoracolumbar Fusion Cages Be Used In The Clinical Trial?
- In Clinical Evaluation Of The Abutment Product, If The Material Of The Product Under Application Is Titanium Alloy (Ti6A14V)5 Is It Possible To Select The Product Made Of Pure Titanium (TA4) As The Predicate Device For Comparison?
- What Clinical Evaluation Data Should Be Submitted For Polyurethane Foam Dressings?
- How To Select The Typical Product In The Test Of Porcelain-fused-to-metal Powder?
- How To Choose Typical Products For Testing Haemoconcentrators And Bilirubin Plasma Hemoperfutor Products?
- There Are A Wide Variety Of Dental Abutments During The Evaluation Of Mechanical Properties (torsional Resistance, Tightening And Fatigue Resistance) Of A Product, How To Select The Investigational Typical Sample?
- How To Determine The Typicality Of Test Samples When Evaluating The Relative Performance Of Dental Impression Materials?